NCT02124954View on ClinicalTrials.gov

A Preliminary Drug Drug Interaction Study With TA-8995

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Pharmacokinetic Interactions
Interventions
DRUG

TA-8995

DRUG

Midazolam

DRUG

Digoxin

Trial Locations (1)

LS2 9LH

Covance, Leeds

All Listed Sponsors
lead

Xention Ltd

INDUSTRY

NCT02124954 - A Preliminary Drug Drug Interaction Study With TA-8995 | Biotech Hunter | Biotech Hunter